Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Jan 3, 2023
Date Accepted: Jun 9, 2023
Date Submitted to PubMed: Aug 25, 2023

The final, peer-reviewed published version of this preprint can be found here:

Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users’ Perspectives: Multicenter, Cross-Sectional Study in Dermatology

Maul LV, Jahn AS, Pamplona GSP, Streit M, Gantenbein L, Müller S, Nielsen ML, Greis C, Navarini AA, Maul JT

Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users’ Perspectives: Multicenter, Cross-Sectional Study in Dermatology

JMIR Dermatol 2023;6:e45384

DOI: 10.2196/45384

PMID: 37582265

PMCID: 10457706

Acceptance of telemedicine compared to in-person consultation from the providers and users’ perspectives: A multicenter, cross-sectional study in dermatology

  • Lara Valeska Maul; 
  • Anna Sophie Jahn; 
  • Gustavo Santo Pedro Pamplona; 
  • Markus Streit; 
  • Lorena Gantenbein; 
  • Simon Müller; 
  • Mia-Louise Nielsen; 
  • Christian Greis; 
  • Alexander A. Navarini; 
  • Julia-Tatjana Maul

ABSTRACT

Background:

Teledermatology is currently finding its place in modern healthcare worldwide as a quickly evolving field.

Objective:

The aim of this study was to investigate the acceptance of teledermatology compared to in-person consultation from the perspective of patients and professionals.

Methods:

This multicenter, cross-sectional pilot study was performed at secondary and tertiary referral centers of Dermatology in Switzerland from August 2019 to January 2020. A customized questionnaire addressing demographics and educational data, experience with telemedicine and presumed willingness to replace in-patient consultations with teledermatology was completed by dermatological patients, dermatologists, and healthcare workers in dermatology.

Results:

Among a total of 664 participants, the ones with previous telemedicine experience (25.8%; 171/664) indicated a high level of overall experience with it (patients: 68.9%, dermatologists: 75.0%, health care workers: 79.4%). Patients, dermatologists, and healthcare workers were most likely willing to replace in-person consultations with teledermatology for minor health issues (P = .029). We observed a higher preference for telemedicine among individuals who have already used telemedicine (patients: P < .001, dermatologists: P = .03, healthcare workers, P = .005), as well as among patients with higher educational levels (P = .003).

Conclusions:

Our study indicates that the preference for teledermatology has high potential to increase over time since previous experience with telemedicine and a higher level of education was associated with a higher willingness to replace in-patient consultations with telemedicine. We assume that minor skin problems are the most promising field for teledermatology. Our findings emphasize the need for dermatologists to be actively involved in the transition to teledermatology. Clinical Trial: ClinicalTrials.gov NCT04495036.


 Citation

Please cite as:

Maul LV, Jahn AS, Pamplona GSP, Streit M, Gantenbein L, Müller S, Nielsen ML, Greis C, Navarini AA, Maul JT

Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users’ Perspectives: Multicenter, Cross-Sectional Study in Dermatology

JMIR Dermatol 2023;6:e45384

DOI: 10.2196/45384

PMID: 37582265

PMCID: 10457706

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.